Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/pharma-price-controls-hurt-consumers-subir-roy-4683108/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/pharma-price-controls-hurt-consumers-subir-roy-4683108/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/pharma-price-controls-hurt-consumers-subir-roy-4683108/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/pharma-price-controls-hurt-consumers-subir-roy-4683108/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0bbdf412ac-trace').style.display = (document.getElementById('cakeErr67f0bbdf412ac-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f0bbdf412ac-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0bbdf412ac-code').style.display = (document.getElementById('cakeErr67f0bbdf412ac-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0bbdf412ac-context').style.display = (document.getElementById('cakeErr67f0bbdf412ac-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f0bbdf412ac-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f0bbdf412ac-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 35002,
		&#039;title&#039; =&gt; &#039;Pharma price controls hurt consumers -Subir Roy&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;
&lt;br /&gt;
First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;
&lt;br /&gt;
Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;
&lt;em&gt;&lt;br /&gt;
Taking a hit&lt;/em&gt;&lt;br /&gt;
&lt;br /&gt;
US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 2 November, 2017, http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;pharma-price-controls-hurt-consumers-subir-roy-4683108&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4683108,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 35002,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Medicine Prices,Access to Medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins

The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;&lt;br /&gt;First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;&lt;br /&gt;Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;&lt;em&gt;&lt;br /&gt;Taking a hit&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot; title=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 35002,
	&#039;title&#039; =&gt; &#039;Pharma price controls hurt consumers -Subir Roy&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;
&lt;br /&gt;
First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;
&lt;br /&gt;
Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;
&lt;em&gt;&lt;br /&gt;
Taking a hit&lt;/em&gt;&lt;br /&gt;
&lt;br /&gt;
US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 2 November, 2017, http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;pharma-price-controls-hurt-consumers-subir-roy-4683108&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4683108,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 35002
$metaTitle = &#039;LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy&#039;
$metaKeywords = &#039;Medicine Prices,Access to Medicines&#039;
$metaDesc = &#039;
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins

The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;&lt;br /&gt;First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;&lt;br /&gt;Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;&lt;em&gt;&lt;br /&gt;Taking a hit&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot; title=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/pharma-price-controls-hurt-consumers-subir-roy-4683108.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy | Im4change.org</title>
    <meta name="description" content="
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins

The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Pharma price controls hurt consumers -Subir Roy</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu Business Line<br /><br /><em>Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins<br /></em><br />The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?<br /><br />First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.<br /><br />Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?<br /><em><br />Taking a hit</em><br /><br />US pharma manufacturer Johnson &amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &ldquo;extreme example&rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &lsquo;generalised system of preferences&rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. <br /><br />Please <a href="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true" title="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true">click here</a> to read more. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0bbdf412ac-trace').style.display = (document.getElementById('cakeErr67f0bbdf412ac-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f0bbdf412ac-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0bbdf412ac-code').style.display = (document.getElementById('cakeErr67f0bbdf412ac-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0bbdf412ac-context').style.display = (document.getElementById('cakeErr67f0bbdf412ac-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f0bbdf412ac-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f0bbdf412ac-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 35002,
		&#039;title&#039; =&gt; &#039;Pharma price controls hurt consumers -Subir Roy&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;
&lt;br /&gt;
First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;
&lt;br /&gt;
Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;
&lt;em&gt;&lt;br /&gt;
Taking a hit&lt;/em&gt;&lt;br /&gt;
&lt;br /&gt;
US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 2 November, 2017, http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;pharma-price-controls-hurt-consumers-subir-roy-4683108&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4683108,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 35002,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Medicine Prices,Access to Medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins

The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;&lt;br /&gt;First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;&lt;br /&gt;Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;&lt;em&gt;&lt;br /&gt;Taking a hit&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot; title=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 35002,
	&#039;title&#039; =&gt; &#039;Pharma price controls hurt consumers -Subir Roy&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;
&lt;br /&gt;
First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;
&lt;br /&gt;
Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;
&lt;em&gt;&lt;br /&gt;
Taking a hit&lt;/em&gt;&lt;br /&gt;
&lt;br /&gt;
US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 2 November, 2017, http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;pharma-price-controls-hurt-consumers-subir-roy-4683108&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4683108,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 35002
$metaTitle = &#039;LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy&#039;
$metaKeywords = &#039;Medicine Prices,Access to Medicines&#039;
$metaDesc = &#039;
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins

The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;&lt;br /&gt;First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;&lt;br /&gt;Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;&lt;em&gt;&lt;br /&gt;Taking a hit&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot; title=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/pharma-price-controls-hurt-consumers-subir-roy-4683108.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy | Im4change.org</title>
    <meta name="description" content="
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins

The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Pharma price controls hurt consumers -Subir Roy</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu Business Line<br /><br /><em>Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins<br /></em><br />The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?<br /><br />First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.<br /><br />Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?<br /><em><br />Taking a hit</em><br /><br />US pharma manufacturer Johnson &amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &ldquo;extreme example&rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &lsquo;generalised system of preferences&rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. <br /><br />Please <a href="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true" title="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true">click here</a> to read more. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0bbdf412ac-trace').style.display = (document.getElementById('cakeErr67f0bbdf412ac-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f0bbdf412ac-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0bbdf412ac-code').style.display = (document.getElementById('cakeErr67f0bbdf412ac-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0bbdf412ac-context').style.display = (document.getElementById('cakeErr67f0bbdf412ac-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f0bbdf412ac-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f0bbdf412ac-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 35002,
		&#039;title&#039; =&gt; &#039;Pharma price controls hurt consumers -Subir Roy&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;
&lt;br /&gt;
First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;
&lt;br /&gt;
Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;
&lt;em&gt;&lt;br /&gt;
Taking a hit&lt;/em&gt;&lt;br /&gt;
&lt;br /&gt;
US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 2 November, 2017, http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;pharma-price-controls-hurt-consumers-subir-roy-4683108&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4683108,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 35002,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Medicine Prices,Access to Medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins

The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;&lt;br /&gt;First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;&lt;br /&gt;Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;&lt;em&gt;&lt;br /&gt;Taking a hit&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot; title=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 35002,
	&#039;title&#039; =&gt; &#039;Pharma price controls hurt consumers -Subir Roy&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;
&lt;br /&gt;
First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;
&lt;br /&gt;
Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;
&lt;em&gt;&lt;br /&gt;
Taking a hit&lt;/em&gt;&lt;br /&gt;
&lt;br /&gt;
US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 2 November, 2017, http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;pharma-price-controls-hurt-consumers-subir-roy-4683108&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4683108,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 35002
$metaTitle = &#039;LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy&#039;
$metaKeywords = &#039;Medicine Prices,Access to Medicines&#039;
$metaDesc = &#039;
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins

The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Public procurement at a negotiated price is a better option. Price curbs deter producers and don&amp;rsquo;t check pharmacy margins&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Government&amp;rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?&lt;br /&gt;&lt;br /&gt;First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &amp;mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.&lt;br /&gt;&lt;br /&gt;Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?&lt;br /&gt;&lt;em&gt;&lt;br /&gt;Taking a hit&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;US pharma manufacturer Johnson &amp;amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &amp;ldquo;extreme example&amp;rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &amp;lsquo;generalised system of preferences&amp;rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. &lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot; title=&quot;http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/pharma-price-controls-hurt-consumers-subir-roy-4683108.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy | Im4change.org</title>
    <meta name="description" content="
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins

The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Pharma price controls hurt consumers -Subir Roy</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu Business Line<br /><br /><em>Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins<br /></em><br />The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?<br /><br />First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.<br /><br />Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?<br /><em><br />Taking a hit</em><br /><br />US pharma manufacturer Johnson &amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &ldquo;extreme example&rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &lsquo;generalised system of preferences&rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. <br /><br />Please <a href="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true" title="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true">click here</a> to read more. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 35002,
		'title' => 'Pharma price controls hurt consumers -Subir Roy',
		'subheading' => '',
		'description' => '<div align="justify">
-The Hindu Business Line<br />
<br />
<em>Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins<br />
</em><br />
The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?<br />
<br />
First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.<br />
<br />
Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?<br />
<em><br />
Taking a hit</em><br />
<br />
US pharma manufacturer Johnson &amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &ldquo;extreme example&rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &lsquo;generalised system of preferences&rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. <br />
<br />
Please <a href="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true">click here</a> to read more. <br />
</div>',
		'credit_writer' => 'The Hindu Business Line, 2 November, 2017, http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'pharma-price-controls-hurt-consumers-subir-roy-4683108',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4683108,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 35002,
	'metaTitle' => 'LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy',
	'metaKeywords' => 'Medicine Prices,Access to Medicines',
	'metaDesc' => '
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins

The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private...',
	'disp' => '<div align="justify">-The Hindu Business Line<br /><br /><em>Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins<br /></em><br />The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?<br /><br />First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.<br /><br />Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?<br /><em><br />Taking a hit</em><br /><br />US pharma manufacturer Johnson &amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &ldquo;extreme example&rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &lsquo;generalised system of preferences&rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. <br /><br />Please <a href="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true" title="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true">click here</a> to read more. <br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 35002,
	'title' => 'Pharma price controls hurt consumers -Subir Roy',
	'subheading' => '',
	'description' => '<div align="justify">
-The Hindu Business Line<br />
<br />
<em>Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins<br />
</em><br />
The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?<br />
<br />
First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.<br />
<br />
Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?<br />
<em><br />
Taking a hit</em><br />
<br />
US pharma manufacturer Johnson &amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &ldquo;extreme example&rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &lsquo;generalised system of preferences&rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. <br />
<br />
Please <a href="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true">click here</a> to read more. <br />
</div>',
	'credit_writer' => 'The Hindu Business Line, 2 November, 2017, http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'pharma-price-controls-hurt-consumers-subir-roy-4683108',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4683108,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 35002
$metaTitle = 'LATEST NEWS UPDATES | Pharma price controls hurt consumers -Subir Roy'
$metaKeywords = 'Medicine Prices,Access to Medicines'
$metaDesc = '
-The Hindu Business Line

Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins

The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private...'
$disp = '<div align="justify">-The Hindu Business Line<br /><br /><em>Public procurement at a negotiated price is a better option. Price curbs deter producers and don&rsquo;t check pharmacy margins<br /></em><br />The Government&rsquo;s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive?<br /><br />First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants &mdash; first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months.<br /><br />Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released?<br /><em><br />Taking a hit</em><br /><br />US pharma manufacturer Johnson &amp; Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an &ldquo;extreme example&rdquo; of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the &lsquo;generalised system of preferences&rsquo; (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. <br /><br />Please <a href="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true" title="http://www.thehindubusinessline.com/opinion/pharma-price-controls-hurt-consumers/article9939882.ece?homepage=true">click here</a> to read more. <br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Pharma price controls hurt consumers -Subir Roy

-The Hindu Business Line Public procurement at a negotiated price is a better option. Price curbs deter producers and don’t check pharmacy margins The Government’s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive? First came the move to extend the scope of what are considered essential medicines so as to bring a larger number of them under price control. Then came the move to impose a cap on the prices of medical implants — first coronary stents and then knee implants. This led to some foreign manufacturers of implants seeking to withdraw some products from the Indian market. The Government refused such permission for six months and over time the original applicants submitted fresh applications to withdraw their products after six months. Now the question is, how long can you prevent manufacturers from withdrawing their products? Are they likely to introduce their newest products in India in future when they are globally released? Taking a hit US pharma manufacturer Johnson & Johnson has taken a $10 million hit in the September quarter on sales of knee implants as a result of price control in India, which it described as an “extreme example” of such action occurring periodically around the world. Also, AdvaMed, a lobby of US medical device manufacturers, has asked the US trade representative to cut duty concessions to Indian imports into the US under the ‘generalised system of preferences’ (GSP) in response to India capping cardiac stents and knee implant prices. Two Indian associations of medical device manufacturers have protested, adding that GSP is a multi-country arrangement and there is a downside to tinkering with it unilaterally. Please click here to read more.